sar425899 sanofi dual glp-1 glucagon agonist Focus on Glucagon-like Peptide-1 Target: Drugs Approved or Designed to Treat Obesity Current GLP-1, GIP, and glucagon

Does the va cover tirzepatide

Thats what makes scientists think these drugs might do far more than manage weight

[DOI] [PubMed] [Google Scholar] 104.Wiviott S.D., Raz I., Bonaca M.P., Mosenzon O., Kato E.T., Cahn A., Silverman M.G., Zelniker T.A., Kuder J.F., Murphy S.A., et al

While it may or may not belong here I think it also prudent to mention DoorDash (DASH) due to a business model that likely thrives on demand for fast food, although I dont have any breakdown to support this, so I wont be including it in the basket

NEW FORMULATION Wegovy is now available as a once-daily oral pill FDA-approved oral GLP-1 Easy, once-daily pill ~14% weight loss at 1 year (similar to injectable) No injections or refrigeration needed Prescription & ongoing care through Healthspan 1 Based on the 64-week OASIS 4 Phase 3 clinical trial of 307 adults with obesity or overweight

However, these potential options have not yet been tested in humans, and there isnt enough evidence to determine their safety or effectiveness for weight loss